Muchiri K, Kayima JK, Ogola EN, McLigeyo S, Ndung’u SW, Kabinga SK. Concordance between bio-impedance analysis and clinical score in fluid-status assessment of maintenance haemodialysis patients: A single centre experience. World J Nephrol 2022; 11(4): 127-138 [PMID: 36161265 DOI: 10.5527/wjn.v11.i4.127]
Corresponding Author of This Article
Samuel K Kabinga, MBChB, MD, Doctor, East African Kidney Institute, University of Nairobi, P.O. Box 30197, Nairobi +254, Kenya. kabingas@yahoo.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jul 25, 2022 (publication date) through Nov 3, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Muchiri K, Kayima JK, Ogola EN, McLigeyo S, Ndung’u SW, Kabinga SK. Concordance between bio-impedance analysis and clinical score in fluid-status assessment of maintenance haemodialysis patients: A single centre experience. World J Nephrol 2022; 11(4): 127-138 [PMID: 36161265 DOI: 10.5527/wjn.v11.i4.127]
World J Nephrol. Jul 25, 2022; 11(4): 127-138 Published online Jul 25, 2022. doi: 10.5527/wjn.v11.i4.127
Concordance between bio-impedance analysis and clinical score in fluid-status assessment of maintenance haemodialysis patients: A single centre experience
Kamiti Muchiri, Joshua K Kayima, Elijah N Ogola, Seth McLigeyo, Sally W Ndung’u, Samuel K Kabinga
Kamiti Muchiri, Joshua K Kayima, Seth McLigeyo, Clinical Medicine and Therapeutics, University of Nairobi, Nairobi +254, Kenya
Elijah N Ogola, Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi +254, Kenya
Sally W Ndung’u, Department of Public Health, University of Nairobi, Nairobi +254, Kenya
Samuel K Kabinga, East African Kidney Institute, University of Nairobi, Nairobi +254, Kenya
Author contributions: Muchiri K, Kayima JK, Ogola EN, McLigeyo S, and Kabinga SK designed and coordinated the study; Muchiri K performed all the study procedures; Ndung’u SW analysed and interpreted the data; Muchiri K, Kabinga SK, and Ndung’u SW wrote the manuscript; and all authors approved the final version of this article.
Institutional review board statement: The study was reviewed by the Kenyatta National Hospital/University of Nairobi Scientific and Ethical Review Committee and approved under proposal number P822/012/2018 prior to initiation.
Informed consent statement: All study participants or their legal guardian provided informed written consent about personal and medical data collection prior to study enrolment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Data can be availed on request.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Samuel K Kabinga, MBChB, MD, Doctor, East African Kidney Institute, University of Nairobi, P.O. Box 30197, Nairobi +254, Kenya. kabingas@yahoo.com
Received: June 19, 2021 Peer-review started: June 19, 2021 First decision: July 31, 2021 Revised: September 19, 2021 Accepted: June 21, 2022 Article in press: June 21, 2022 Published online: July 25, 2022 Processing time: 395 Days and 21.4 Hours
Core Tip
Core Tip: Bio-impedance analysis (BIA) has been validated as an accurate and reliable tool for determining fluid status in chronic kidney disease (CKD) patients but is not widely available in low-income settings. In this study we assess how a clinical score (CS) compares with BIA in this population for possible use as a low-cost substitute where BIA is not available. Patients with a CS score greater than 4 were considered to have fluid overload (FO), and detected using this parameter in 58.75% of patients. CSs of ≤ 4 represented no FO, and represented 41.25% of patients. The CS had a sensitivity of 63% and a specificity of 78% in making a diagnosis of FO compared with BIA, which was used as the reference in patients with CKD on maintenance haemodialysis.
